World Microfluidics Market - Opportunities and Forecasts, 2017 - 2023

  • ID: 3773641
  • Report
  • Region: Global
  • Allied Analytics LLP
1 of 2
The microfluidics market provides practical application of small fluid volumes for design of systems and development of solutions. The global healthcare technology market is estimated to reach $53 billion by 2014 at a CAGR of 16%. Microfluidics is an emerging technology with growing acceptability in healthcare applications. The key driver for the microfluidics market is the -great (or rising) demand in point-of-care (POC) and in-vitro diagnostics. For example, according to World Health Organization (WHO), 95 million people received HIV testing in low and middle-income countries in 2010. Application of microfluidics in HIV testing at POCs is expected to cut cost, thereby increase the demand for the technology.

However, several regulatory standards are being made for the implementation of microfluidics in healthcare. The regulatory standards consume too much time for the approval process of microfluidics devices. Another challenge for the growth of the market is the implementation of emerging microfluidics technology in existing applications. To overcome this challenge, companies are investing in research and development.

Key companies profiled in this report are Abbott Laboratories, Inc., Perkinelmer, Inc., Cepheid, Inc., Raindance Technologies, Becton, Dickinson, Bio-Rad Laboratories, Inc., Johnson & Johnson, Life Technologies Corporation, Microfluidic Chipshop GMBH and Siemens Healthcare.

KEY BENEFITS

This report provides market intelligence with respect to technology, components and geographies
Deep dive analysis of top factors impacting the market growth
Value chain analysis, Porter’s five forces, top investment pockets are analyzed and presented in detail in the report
SWOT analysis and strategic developments are included in the report for key players so that companies can understand the competitive landscape and make alterations in their plans
Examine the challenges and opportunities in the microfluidics market so that companies can capitalize in the opportunities and increase revenue
Estimations are derived from the current market scenario and expected future trends chalked out for the period of 2013-2020 with 2012 as historic figures
To analyze the key strategies adopted by major market players engaged in the market
Geographic analysis offers in-depth implications of the trends in various regions; therefore, companies can make region specific strategies to gain competitive advantages
The report provides impact analysis of the drivers, restraints and opportunities for short and mid-term

KEY MARKET SEGMENTSGLOBAL MARKET, BY MATERIAL TYPE

Silicon-Based Microfluidics
Glass-Based Microfluidics
Polymer-Based Microfluidics
Other Materials-Based (Paper & Ceramics) Microfluidics

GLOBAL MARKET, BY INDUSTRY

Pharmaceuticals

Microfluidic Chips for Lab Analytics
Accurate Dispensing Devices
Microreactors for Drug Synthesis

Drug Delivery Devices

Inhaler Nozzles
Microneedles
Micropumps

In-Vitro Diagnostics

Clinical Diagnostics
Point-of-Care (POC)
Environmental Testing
Industrial Testing
Agro Food Testing

GLOBAL MARKET, BY APPLICATION

Industrial & Environmental
Drug Delivery
Pharmaceutical & Life Science Research
Analysis (Toxicity Screening, Proteomic Analysis & Gene Sequencing)
Clinical & Veterinary Diagnostics
Point of Care Diagnostics

GLOBAL MARKET, BY GEOGRAPHY

North America
Europe
Asia-Pacific
RoW

KEY AUDIENCES

Companies dealing in Microfluidics
Venture capitalists and investors interested in this market
Research organizations



* This report will be delivered in 12 Business Days. *
READ MORE
Note: Product cover images may vary from those shown
2 of 2

Loading
LOADING...

3 of 2
Note: Product cover images may vary from those shown
Adroll
adroll